Polycystic ovaries in women with gestational diabetes

Obstetrical and Gynecological Survey

Volumn 92, Issue 1, 1998, Pages 13-16

  Anttila, L ^a   Karjala, K ^a   Penttila, T A ^a   Ruutiainen, K ^a   Ekblad, U ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; SYNDROME X; TRANSVAGINAL ECHOGRAPHY;

ADULT; DIABETES, GESTATIONAL; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 0032125473     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1080/00006250-199807000-00003     Document Type: Article

References (24)

1. Reaven GM. Syndrome X: 6 years later. J Intern Med 1994; 236(suppl 736):13-22.
2. Wild RA. Hyperandrogenism: Implications for cardiovascular disease. In: Redmond GP, ed. Androgenic disorders. 1st ed. New York: Raven Press, 1995:261-278.
3. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992;7:505-513.
4. Conway G, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;37:19-25.
5. Holte J, Berg T, Berne C, Lithell H. Serum lipoprotein lipid profile in women with polycystic ovary syndrome: Relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf) 1994;41:463-471.
6. Holte J, Berg T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995;80:2586-2593.
7. Knopp RH, Montes A, Childs M. Metabolic adjustments in normal and diabetic pregnancy. Clin Obstet Gynecol 1981;24:21-49.
8. Nobles F, Dewailly D. Puberty and polycystic ovarian syndrome: The insulin/insulin-like growth factor I hypothesis. Fertil Steril 1992;58:655-666.
9. Kuhl C, Hornnes PJ, Anderssen O. Etiology and pathophysiology of gestational diabetes mellitus. Diabetes 1985;34(suppl 2):66-70.
10. Stowers J, Hamish W, Kerridge D. Long range implications for the mother. Diabetes 1985;34(suppl 2):106-110.
11. Buschard K, Buch I, Molsted-Pedersen L, Hougaard P, Kuhl C. Increased incidence of true type I diabetes acquired during pregnancy. BMJ 1987;294:275-279.
12. Lanzone A, Fulghesu AM, Cucinelli F, Guido M, Pavone V, Caruso A, et al. Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome. Hum Reprod 1996;11:2382-2386.
13. Norman RJ, Hague WM, Masters SC, Wang XJ. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod 1995;10:2258-2261.
14. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose tolerance. Diabetes 1979; 28:1039-1057.
15. Adams J, Polson DW, Abdulwahid N, Morris DW, Franks S, Mason HD, et al. Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985;1:1315-1318.
16. Ardaens Y, Robert Y, Lemaitre L, Fossati P, Dewailly D. Polycystic ovarian disease: Contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil Steril 1991;55:1062-1068.
17. Pache TD, de Jong FH, Hop WC, Fauser BCJM. Association between ovarian changes assessed by transvaginal ultrasonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil Steril 1993;59:544-549.
18. Takahashi K, Eda Y, Abu-Musa A, Okada S, Yoshuno K, Kitao M. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome. Hum Reprod 1994;9:1231-1236.
19. Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) 1992;37:127-134.
20. O'Meara NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield BL, et al. Defects in b-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993;76:1241-1247.
21. Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:942-947.
22. Gønnaess H. The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: The influence of body-weight. Br J Obstet Gynaecol 1989;96:714-719.
23. Kissebah AK, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-260.
24. Hod M, Merlob P, Friedman S, Schoenfeld A, Ovadia J. A survey of perinatal complications in the 1980s. Diabetes 1991;40(suppl 2):74-78.